TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Human Longevity Stock

Human Longevity Stock

www.humanlongevity.comHealthcareFounded: 2013Funding to Date: $49.3MM

Human Longevity is a genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data.

Buy or sell Human Longevity stockLearn more about Human Longevity IPO
Register for Details

For more details on financing and valuation for Human Longevity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Human Longevity.

Register Today

Human Longevity investors also invested in these private companies

GE Ventures
Draper Fisher Jurvetson
Illumina
Amino Capital
Celgene
Synthetic Genomics
StartUp Health

Team

Management Team

Felix Frueh
Chief Scientific Officer
Yaron Turpaz
Chief Information Officer
Williams Biggs
Head, Genomic Sequencing
J. Venter
Co-founder and CEO

Board Members

David Brenner
University of California, San Diego
James Brewer
University of California, San Diego
Delos Cosgrove
Cleveland Clinic
Eric Anderson
Intentional Software

Other companies like Human Longevity in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Reuters 06/24/2022
Human Longevity plans to go public in $1B blank-check deal
The genome sequencing company plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1B.
Xconomy 01/13/2020
Xconomy: NeoGenomics Nabs Human Longevity’s Oncology Division for $37M
The genetic testing company NeoGenomics has acquired Human Longevity’s oncology division, which provides next-generation sequencing services. The division
Forbes 01/06/2019
A Deeper Look At Human Longevity Genes
Dr. Nir Barzilai, a Milken Institute Center for the Future on Aging Longevity Innovator, discusses his latest research and what's ahead.

Trending Companies

Frequently Asked Questions